Moreover, in the 11C-CFT DAT and PDRP via 18F-FDG PET studies, patients were found to have decreased DAT availability and PD-like metabolic pattern, making the correct diagnosis of the disease quite difficult in the absence of molecular genetic diagnosis. Here, SLC6A3 is linked to Parkinson disease.